Ophthamologist Alan Scott Dies at Age 89

The Smith-Kettlewell Eye Research Institute scientist developed Botox for medicinal use.

young woman smiling
| 2 min read
headshot of a man
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Alan Scott died on December 16 after suffering from an acute illness, reports NPR. His research focused on treating eye muscle disorders and led to the development of what is commercially known as Botox.

Born in Berkeley in 1932, Scott attended the University of California, Berkeley, where he earned a bachelor’s in medical sciences. He then continued studying medicine, completing his MD in 1956 at the University of California, San Francisco, according to the American Association for Pediatric Ophthamology and Strabismus. After graduating, he spent the next five years working in residencies in neurosurgery and ophthalmology at the University of Minnesota and Stanford University, respectively. For most of his research career, Scott worked at the Smith-Kettlewell Eye Research Institute in San Francisco.

Scott’s most notable scientific contribution centered around the botulinum toxin produced by Clostridium botulinum bacteria, which causes the severe illness botulism. According to the Centers for Disease Control ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • young woman smiling

    Chloe Tenn

    Chloe Tenn is a graduate of North Carolina State University, where she studied neurobiology, English, and forensic science. Fascinated by the intersection of science and society, she has written for organizations such as NC Sea Grant and the Smithsonian. Chloe also works as a freelancer with AZoNetwork, where she ghostwrites content for biotechnology, pharmaceutical, food, energy, and environmental companies. She recently completed her MSc Science Communication from the University of Manchester, where she researched how online communication impacts disease stigma. You can check out more of her work here.

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours